Hyperglycemia in the hospital is associated with increased morbidity such as higher rates of infection and cardiac events. Cleveland Clinic endocrinologists are working to reduce the risks.
Ketogenic Diets in the Management of Type 1 Diabetes: Safe or Safety Concern?
As the ketogenic diet’s popularity rises, certain considerations need to be taken when recommending it for patients with Type 1 diabetes.
Therapeutic Approaches for the Treatment of Pre-Diabetes: Glucocentric vs. Adipocentric
Should the primary focus of pre-diabetes treatment be glucose control or weight loss? Bartolome Burguera, MD, PhD, Chairman of Cleveland Clinic’s Endocrinology and Metabolism Institute, discusses the two different treatment scenarios.
Possible Side Effects of Metformin Use in Patients with Type 2 Diabetes
Metformin should be considered in all adult patients with type 2 diabetes; gradual titration and extended release formulation should reduce adverse effects.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Distinctive Dozen: 12 Developments from 2016 Likely to Reshape Cardiovascular Practice
From heart benefits of diabetes drugs to leadless pacing to expanding populations for TAVR, 2016 was a dynamic year in cardiovascular care. Cleveland Clinic experts reflect on a dozen key developments.
Study Looks at Insulin Requirements After Bariatric Surgery
At AACE Cleveland Clinic researchers presented results of a study comparing pre- and post-operative insulin regimens and dosages in patients with T2D who had undergone gastric bypass.
Final STAMPEDE Results: Glycemic Benefits of Bariatric Surgery Persist Over Time
Five-year results from the pivotal STAMPEDE trial confirm those of interim reports, with bariatric surgery’s advantage over intensive medical therapy for diabetes appearing to widen over time.